SEAAIS 2020 75th Annual Meeting
The SEAAIS 2020 virtual meeting will provide learners with knowledge regarding novel disease state developments and the expanding therapeutic armamentarium in the field of allergy, asthma and immunology. Learners will not only gain insights with regard to selecting the best therapeutic alternative for each patient, but they will also have the opportunity to develop novel strategies designed to enhance therapeutic adherence through shared decision making.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and Southeastern Allergy, Asthma and Immunology Society. The American College of Allergy, Asthma and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 9.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American College of Allergy, Asthma & Immunology (ACAAI) is a provider, approved by the California Board of Registered Nursing, Provider Number CEP17239, for 9.5 contact hours.
This activity is supported by educational grants from CSL Behring and Astra Zeneca.
Allied health professionals
Upon completion of this activity the participant should be able to:
- Examine biologics available for the treatment of asthma and discuss recommendations that can be made choosing a biologic for an asthma patient.
- Examine testing methods for metal allergy patients.
- Review common dermatologic conditions treated by allergists and identify improved treatment options.
- Review other uses for biologics such as treating hives and nasal polyps.
- Review USP guidelines and updates for compliance.
- Illustrate lean processes that providers can implement to increase efficiency and discuss major sources with literature where they can learn about lean healthcare.
- Review guidelines and principles to assist providers with the recognition, diagnosis and management of patients with occupational asthma.
- Illustrate the clinical manifestation of exercise-induced anaphylaxis and discuss the pathophysiologic events during exercise that precipitate symptoms.
All identified conflicts of interest have been resolved.
Lee S. Clore, Jr., MD – CME Planner, Moderator
Speaker/honorarium – Boehringer Ingelheim, Genentech, GSK, Regeneron
Advisor Board Member/honorarium – GSK, Pfizer, Sanofi
Patricia Stewart, MD – CME Planner
Speaker/honorarium – Genentech
Thomas Casale, MD – Speaker
Speaker/honorarium – Genentech
Consultant/consulting fees – Genentech, Regeneron, Sanofi
Advisory Board/honorarium – AstraZeneca, GSK
Author/honorarium – Genentech
DSMB/honorarium - Novartis
David Cohen, MD – Speaker
Consultant/consulting fees – Dermavant, Dermira, Evommune, Leo, Ferndale, Medimetriks, UCB
Advisory Board/honorarium – Asana, Leo, UCB
Mike Tankersley, MD – Speaker
Consultant/consulting fees – ALK
James Tracy, DO – Speaker
Consultant/consulting fees – Thermo Fisher
Advisory Board/honorarium - Pharming
The following have nothing to disclose:
Jean L. Owen, MBA – Meeting Planner
Anna Feldweg, MD – Speaker
Alexandra Freeman, MD – Speaker
Jerome Goddard, PhD – Speaker
Stephen LeBlanc, MD - Speaker
Karin Pacheco, MD – Speaker
Panida Sriaroon, MD – Speaker
- 9.50 AMA PRA Category 1 Credit™
- 9.50 Attendance
- 9.50 CBRN